View the latest clinical trials, studies, data, and updates.
The objective of the study is to collect ‘real-world’ safety, efficacy, health economics, and patient-reported quality-of-life data in over 700 patients with PAD treated with SELUTION SLR.
Fe bruary 1, 2021 PRELUDE-BTK Study was presented at this year’s LINC Symposium on January 29th. PRELUDE-BTK Study, was a prospective, single-arm, multi-center feasibility study
PRESTIGE* is a prospective, single-center, physician-initiated clinical study, run at the Singapore General Hospital (SGH) by Associate Professor Tze Tec Chong and Dr. Tjun Yip Tang.
FLEX VP System is designed to modify plaque and prepare vessels with complex femoropopliteal arterial disease, including in-stent restenotic (ISR) lesions, prior to delivery of the definitive therapy.
Simon Hubbert, Chief Executive of RHYTHM AI Ltd, commented: “We are encouraged to see additional, positive data demonstrating the superior results of STAR Mapping in the treatment of persistent AF, which has historically proved difficult to treat with conventional ablation therapy.
The ILLUMENATE EU RCT and ILLUMENATE Pivotal RCT together comprised approximately 600 patients in Europe and the U.S.